Qiming Venture Partners
Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Nanotechnology
Novamab
Series B in 2024
Novamab is a biotechnology company specializing in the development of novel nanobodies, a type of single-domain antibody with unique therapeutic advantages. With over 15 years of experience in nanobody research and development, the company's team of pioneers in this field has established platforms to maximize the potential of nanobodies. Novamab focuses on creating innovative drug formulations such as inhaled macromolecular drugs, albumin nanobody long-acting therapies, and nanobody double-antibody combinations. Their primary goal is to address unmet clinical needs by improving administration methods and reducing treatment cycles for major chronic diseases like cancer, autoimmune disorders, and cardiovascular conditions.
Horizone Technologies
Series A in 2024
Horizone Technologies is membrane materials and excellent filtration solutions manufacturer focusing on the R&D and production
Silicon Yi Technology
Venture Round in 2024
Silicon Yi Technology is a biotech firm specializing in RNA nanopesticide research and development designed to target pests and diseases.
Lixin Huigan
Series A in 2023
Lixin Huigan is a full-service manufacturer of sensors and an application service provider with an emphasis on the creation of premium micro-nanosensors.
Resunbio
Series A in 2022
Resunbio provides micro-nano processing research and development precipitation.
Resunbio is headquartered in Longhua, China.
BTR
Series A in 2010
BTR is a specialized manufacturer dedicated to the production of positive and negative electrode materials for lithium-ion secondary batteries, as well as the application of nanometer materials. The company engages in research, development, production, and sales of products associated with lithium-ion batteries. BTR is owned by China Baoan Group and plays a significant role in the battery materials industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.